Acute lymphoblastic leukaemia
This review discusses the management of acute lymphoblastic leukaemia, noting that new immunotherapeutic strategies (e.g. monoclonal antibodies and chimeric antigen receptor (CAR) T cells) are being developed and could change treatment options over the coming years.
Source:
The Lancet